Operating Lease, Right-of-Use Asset of Olema Pharmaceuticals, Inc. from 31 Dec 2021 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Olema Pharmaceuticals, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2021 to 30 Sep 2025.
  • Olema Pharmaceuticals, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $1,419,000, a 9.4% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Olema Pharmaceuticals, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $1,419,000 -$148,000 -9.4% 30 Sep 2025 10-Q 10 Nov 2025 2025 Q3
Q2 2025 $1,685,000 -$129,000 -7.1% 30 Jun 2025 10-Q 11 Aug 2025 2025 Q2
Q1 2025 $1,055,000 -$1,000,000 -49% 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q4 2024 $1,314,000 -$977,000 -43% 31 Dec 2024 10-Q 10 Nov 2025 2025 Q3
Q3 2024 $1,567,000 -$991,000 -39% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 $1,814,000 -$124,000 -6.4% 30 Jun 2024 10-Q 06 Aug 2024 2024 Q2
Q1 2024 $2,055,000 -$165,000 -7.4% 31 Mar 2024 10-Q 08 May 2024 2024 Q1
Q4 2023 $2,291,000 -$204,000 -8.2% 31 Dec 2023 10-K 18 Mar 2025 2024 FY
Q3 2023 $2,558,000 -$206,000 -7.5% 30 Sep 2023 10-Q 07 Nov 2023 2023 Q3
Q2 2023 $1,938,000 -$1,090,000 -36% 30 Jun 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 $2,220,000 -$770,000 -26% 31 Mar 2023 10-Q 09 May 2023 2023 Q1
Q4 2022 $2,495,000 -$751,000 -23% 31 Dec 2022 10-K 11 Mar 2024 2023 FY
Q3 2022 $2,764,000 30 Sep 2022 10-Q 08 Nov 2022 2022 Q3
Q2 2022 $3,028,000 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 $2,990,000 31 Mar 2022 10-Q 09 May 2022 2022 Q1
Q4 2021 $3,246,000 31 Dec 2021 10-K 09 Mar 2023 2022 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.